CLINICAL ROLE -
FDA Approves Alectinib to Treat Patients With ALK-Positive NSCLC
With this approval, alectinib is the first anaplastic lymphoma kinase inhibitor to be approved for patients with ALK-positive, early-stage non-small cell lung cancer.
Read More
Positive Data Demonstrates Gepotidacin is Non-Inferior to Alternative Treatment in GC
In a trial that compared gepotidacin to ceftriaxone plus azithromycin in patients with urogenital gonorrhea, gepotidacin presented a 92.6% microbiological success rate.
Study: Chemotherapy to Treat Breast Cancer Increases Risk of Lung Cancer
Individuals treated with chemotherapy following a breast cancer diagnosis were more at risk of developing second primary lung cancer.
Questions Remain About How Pharmacists Can Integrate Into Food Pharmacies
Regardless of how this fits into workflow, pharmacists can play a significant role in counseling patients on nutrition and holistic health.
Watch
Gap in Medicaid Impacts Access to Services for Justice-Involved Patients
Patients who were formerly incarcerated commonly experience substance use disorder, tuberculosis, hepatitis C, and sexually transmitted diseases
Climate Change Increases Rate of Infectious Diseases, Expert Says
Speaker Monica Diaz describes the detrimental impact climate change has on the transmission and increases in infectious disease cases.
Durvalumab With Chemotherapy Shows Long-Term Overall Survival at 3 Years
The results were the longest survival follow-up ever reported for a phase 3 trial for biliary tract cancer.
Middletown Pharmacy and Wellness Staff Care for the Community
Tara Schneider, PharmD, and her husband, Chuck Schneider, MBA, offer expanded clinical services in their Louisville, Kentucky, pharmacy.
RSV Vaccine Could Prevent Increased Risk of Disease Among Individuals Aged 18 to 59
The results displayed well tolerability and safety with Abrysvo, meeting the study’s co-primary endpoint of immunogenicity and primary safety
Pharmacists Can Improve Access to Pharmacogenomics
Adrijana Kekic, PharmD, a pharmacogenomics clinical specialist with Mayo Clinic in Phoenix, Arizona, discussed current guidelines for pharmacogenomics.
OTC Contraception Opens New Opportunities for Counseling Patients
With the first FDA-approved option hitting shelves soon, pharmacists can advise patients on the best methods to prevent pregnancy
Making Residency Research Projects Patient Centered: How Retrospective Research Can Significantly Impact Cancer Care
Through recognizing the importance of research in the scope of pharmacy practice by national pharmacy organizations, research can become a prominent role and responsibility of pharmacy.
Tirzepatide Demonstrates Reduction in Sleep Apnea-Relate Events
Eli Lilly and Company will submit results of the study to support tirzepatide (Zepbound) for treatment of obstructive sleep apnea later this year.
Enfortumab Vedotin With Pembrolizumab Shows Promise as First-Line Therapy For Those Ineligible for Cisplatin
Enfortumab vedotin in combination with pembrolizumab showed a manageable safety profile and promising progression free survival and overall survival for locally advanced or metastatic urothelial cancer.
FDA Grants Fast Track Designation for TLX101-CDx, an Investigational Glioma Imaging Product
The product is currently being investigated alongside TLX101 in the IPAX-Linz and IPAX-2 clinical trials, and have previously shown efficacy in the IPAX-1 trial.
Pharmacist Prescribing of Contraception Could Improve Access
Pharmacists can play important roles in counseling patients and, in some states, prescribing contraception.
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
IMPACT CKD, a modeling analysis created by AstraZeneca, includes data about chronic kidney disease across 8 countries, including the United States.
FDA Approves Ustekinumab Biosimilar to Stelara for Treatment of Plaque Psoriasis
Ustekinumab (Stelara; Janssen Immunology) is a human monoclonal antibody that treats immune-mediated diseases such as psoriasis and psoriatic arthritis.
Understand the Impact of the ACA on Women’s Equity and Accessible Contraceptives
Access to birth control is a crucial part of preventive health care, but financial barriers persist
Pharmacist Spotlight: Christian Hartman, PharmD, MBA, FSMSO
Pirtobrutinib and BTK Inhibitors in the CLL Treatment Landscape
This review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia.
FDA Grants Breakthrough Device Designation to Assay Supporting Earlier Diagnosis of Alzheimer Disease
If approved, the test could provide more timely and accurate diagnosis, hopefully mitigating the impact of Alzheimer disease (AD) on individuals and the community.
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
AI offers many benefits in health professions by efficiently handling time-consuming tasks crucial for patient care.
Study Details Benefits, Therapeutic Effects of Medical Marijuana on Patients’ Quality of Life
The study is the first of 5 studies co-published by AYR Wellness and LECOM and showcases improvements in physical, social, and mental well-being with minimal AEs.
Semaglutide's New Indication Highlights Growing Role of GLP-1 Receptor Agonists
The latest FDA approval paves the way for expanded use of GLP-1 receptor agonists in patients without diabetes.
Extension Trial Analysis Shows Long-Term Safety, Efficacy of Atogepant in Patients With Migraines
The extension trial of atogepant demonstrated an 8.5-day improvement of monthly migraine days at weeks 13 through 16 and no new safety signals were observed.
FDA Accepts Application for 5-in-1 Meningococcal Vaccine Candidate
The 5-in-1 meningococcal ABCWY vaccine candidate has an assigned Prescription Drug User Fee Act action date of February 14, 2025.
GLPs Are the Latest Example of the Shift to Alternative Purchasing Models
Erectile dysfunction medications started the shift, then coinsurance, deductibles, and the COVID-19 pandemic accelerated it.
Study: Asthma Diagnosis in Children Does Not Appear Linked to COVID-19 Diagnosis
The authors note that additional research needs to be conducted to confirm whether the findings are consistent in adult patients.
Psychedelics Present Unique Ethical Challenges
Sa’ed Al-Olimat, PharmD, co-founder of the Psychedelic Pharmacists Association, discussed the future of psychedelic medicines and the unique ethical challenges they present.